To manage long COVID by selective SARS-CoV-2 infection biosensing

Innovation (Camb). 2022 Sep 13;3(5):100303. doi: 10.1016/j.xinn.2022.100303. Epub 2022 Aug 11.

Authors

Ajeet Kaushik¹, Ebrahim Mostafavi^{2

3}

Affiliations

¹ NanoBiotech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, Lakeland, FL, USA.
² Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
³ Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

No abstract available

Keywords: SARS-CoV-2 infection; biosensor; long COVID; personalized COVID-19 management; point-of-care systems.

Publication types

Editorial

Grants and funding

T32 EB009035/EB/NIBIB NIH HHS/United States